Chile develops new nanomaterials for cancer diagnosis

Chile’s Talca University announced on the 14th that its researchers have made new breakthroughs in the use of nanotechnology in the diagnosis of cancer. A new type of nanocomposite developed by them can be used for the early diagnosis of cancer.

According to Gonzalez Niro, director of the Center for Bioinformatics and Molecular Simulation of the University of Talca, who participated in the study, this novel nanocomposite material can identify and mark cancer cell molecules, making early diagnosis of cancer more effective; Nanocomposites can also deliver anticancer drugs directly to the lesion cells, giving patients better sensitivity to drugs.

Nero said that the new nanocomposite consists of three molecules, one of which is able to polymerize with cancer cell membrane receptors and can detect cancer cells in the early stage of cancer. Compared with traditional fluorescence imaging detection technology, the use of this nanocomposite to detect cancer cells is more accurate and can be used for the early diagnosis of breast cancer and other cancers.